Annual report pursuant to Section 13 and 15(d)

Accrued Expenses

v3.8.0.1
Accrued Expenses
12 Months Ended
Dec. 31, 2017
Accrued Expenses  
Accrued Expenses

7. Accrued Expenses

Accrued expenses consist of the following (in thousands):

 

 

 

 

 

 

 

 

 

    

December 31, 2017

    

December 31, 2016

 

External research and preclinical development

 

$

5,875

 

$

3,290

 

Employee compensation and benefits

 

 

2,494

 

 

1,911

 

Professional fees

 

 

1,225

 

 

819

 

Facilities

 

 

134

 

 

90

 

Restricted stock liability

 

 

 —

 

 

 5

 

 

 

$

9,728

 

$

6,115